US20100119521A1 - Compositions and methods for treating cancer by modulating her-2 and egf receptors - Google Patents

Compositions and methods for treating cancer by modulating her-2 and egf receptors Download PDF

Info

Publication number
US20100119521A1
US20100119521A1 US12/606,094 US60609409A US2010119521A1 US 20100119521 A1 US20100119521 A1 US 20100119521A1 US 60609409 A US60609409 A US 60609409A US 2010119521 A1 US2010119521 A1 US 2010119521A1
Authority
US
United States
Prior art keywords
herstatin
p185her
sequence
egf receptor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/606,094
Inventor
Gail M. Clinton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/638,834 priority Critical patent/US7396810B1/en
Priority to US10/344,470 priority patent/US7608269B2/en
Priority to PCT/US2001/025502 priority patent/WO2002014470A2/en
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Priority to US12/606,094 priority patent/US20100119521A1/en
Assigned to OREGON HEALTH & SCIENCE UNIVERSITY reassignment OREGON HEALTH & SCIENCE UNIVERSITY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CLINTON, GAIL M.
Publication of US20100119521A1 publication Critical patent/US20100119521A1/en
Application status is Abandoned legal-status Critical

Links